No detection of human bocavirus in amniotic fluid samples from fetuses with hydrops or isolated effusions

Journal of Clinical Virology

Volumn 45, Issue 4, 2009, Pages 300-303

  Enders, Martin ^a   Lindner, Juha ^b   Wenzel, Jürgen J ^b   Baisch, Carola ^a   Schalasta, Gunnar ^a   Enders, Gisela ^a   Modrow, Susanne ^b  

^a Labor Prof Enders und Partner   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Fetus; Human bocavirus; Hydrops; Parvovirus B19; Pregnancy

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS DNA;

ADULT; AMNION FLUID; ANEMIA; ANTIBODY DETECTION; ARTICLE; BOCAVIRUS; CONTROLLED STUDY; ECHOGRAPHY; EFFUSION; ENZYME IMMUNOASSAY; FEMALE; FETUS; FETUS HYDROPS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LIKE AGENT; VIRUS STRAIN;

ADULT; AMNIOTIC FLUID; ANEMIA; ANIMALS; ANTIBODIES, VIRAL; BOCAVIRUS; EDEMA; FEMALE; FETAL DISEASES; FETUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE;

EID: 67649666990     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.04.005     Document Type: Article

References (24)

1. Tolfvenstam T., Papadogiannakis N., Norbeck O., Petersson K., and Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 357 (2001) 1494-1497
2. Enders M., Weidner A., Zoellner I., Searle K., and Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24 (2004) 513-518
3. Valeur-Jensen A.K., Pedersen C.B., Westergaard T., Jensen I.P., Lebech M., Andersen P.K., et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 281 (1999) 1099-1105
4. Enders M., Weidner A., and Enders G. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect 135 (2007) 563-569
5. Lindner J., Karalar L., Schimanski S., Pfister H., Struff W., and Modrow S. Clinical and epidemiological aspects of human bocavirus infection. J Clin Virol 43 (2008) 391-395
6. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., and Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 102 (2005) 12891-12896
7. Kantola K., Hedman L., Allander T., Jartti T., Lehtinen P., Ruuskanen O., et al. Serodiagnosis of human bocavirus infection. Clin Infect Dis 46 (2008) 540-546
8. Lindner J., Zehentmeier S., Franssila R., Barabas S., Schroeder J., Deml L., et al. CD4+ T helper cell responses against human bocavirus viral protein 2 viruslike particles in healthy adults. J Infect Dis 198 (2008) 1677-1684
9. Carmichael L.E., Schlafer D.H., and Hashimoto A. Pathogenicity of minute virus of canines (MVC) for the canine fetus. Cornell Vet 81 (1991) 151-171
10. Manteufel J., and Truyen U. Animal bocaviruses: a brief review. Intervirology 51 (2008) 328-334
11. Schalasta G., Schmid M., Lachmund T., and Enders G. LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates. J Med Virol 73 (2004) 54-59
12. Enders M., Schalasta G., Baisch C., Weidner A., Pukkila L., Kaikkonen L., et al. Human parvovirus B19 infection during pregnancy-value of modern molecular and serological diagnostics. J Clin Virol 35 (2006) 400-406
13. Schenk T., Enders M., Pollak S., Hahn R., and Huzly D. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol 47 (2009) 106-110
14. Liefeldt L., Plentz A., Klempa B., Kershaw O., Endres A.S., Raab U., et al. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 75 (2005) 161-169
15. Lindner J., Karalar L., Zehentmeier S., Plentz A., Pfister H., Struff W., et al. Humoral immune response against human Bocavirus VP2 virus-like particles. Viral Immunol 21 (2008) 443-449
16. Searle K., Guilliard C., and Enders G. Parvovirus B19 diagnosis in pregnant women-quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum. Infection 25 (1997) 32-34
17. Cohen B., and Kumar S. Parvovirus B19 infection in pregnancy. Fetal Matern Med Rev 16 (2005) 123-150
18. Manning A., Willey S.J., Bell J.E., and Simmonds P. Comparison of tissue distribution, persistence and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 195 (2007) 1345-1352
19. Barron S.D., and Pass R.F. Infectious causes of hydrops fetalis. Semin Perinatol 19 (1995) 493-501
20. Black L.D., and Maheshwari A. Disorders of the fetomaternal unit: hematologic manifestations in the fetus and neonate. Semin Perinatol 33 (2009) 12-19
21. de Haan T.R., Beersma M.F.C., Oepkes D., de Jong E.P., Kroes A.C.M., and Walther F.J. Parvovirus B19 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters. Prenat Diagn 27 (2007) 46-50
22. Parilla B.V., Tamura R.K., and Ginsberg N.A. Association of parvovirus infection with isolated fetal effusions. Am J Perinatol 14 (1997) 357-358
23. Enders M., Weidner A., Rosenthal T., Baisch C., Hedman L., Söderlund-Venermo M., et al. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis 197 (2008) 58-62
24. Kahn J.S., Kesebir D., Cotmore S.F., D'Abramo Jr. A., Cosby C., Weibel C., et al. Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis 198 (2008) 41-50